Serum 25-hydroxyvitamin d concentration and risk of dementia. 2014

Paul Knekt, and Katri Sääksjärvi, and Ritva Järvinen, and Jukka Marniemi, and Satu Männistö, and Noora Kanerva, and Markku Heliövaara
From the aNational Institute for Health and Welfare, Helsinki, Finland; and bUniversity of Eastern Finland, Kuopio, Finland.

BACKGROUND High vitamin D status has been hypothesized to protect against dementia. The aim of the current study was to investigate whether serum 25-hydroxyvitamin D (25(OH)D) level predicts dementia risk. METHODS The study was based on the Mini-Finland Health Survey. The study population consisted of 5010 men and women, aged 40-79 years, and free of dementia at baseline. During a 17-year follow up, 151 incident cases of dementia (International Classification of Diseases, revision 8, code 290) occurred, according to population registers. Serum 25(OH)D concentration was determined from serum samples frozen at -20 °C and stored at baseline. RESULTS Among women, these with higher serum 25(OH)D concentrations showed a reduced risk of dementia. The hazard ratio between the highest and lowest quartiles of serum 25(OH)D was 0.33 (95% confidence interval = 0.15-0.73) in women and 0.74 (0.29-1.88) in men, after adjustment for age, month of blood draw, education, marital status, physical activity, smoking, alcohol consumption, body mass index, blood pressure, plasma fasting glucose, serum triglycerides, and serum total cholesterol. CONCLUSIONS The results are in line with the hypothesis that low vitamin D status may be a risk factor for dementia.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011795 Surveys and Questionnaires Collections of data obtained from voluntary subjects. The information usually takes the form of answers to questions, or suggestions. Community Survey,Nonrespondent,Questionnaire,Questionnaires,Respondent,Survey,Survey Method,Survey Methods,Surveys,Baseline Survey,Community Surveys,Methodology, Survey,Nonrespondents,Questionnaire Design,Randomized Response Technique,Repeated Rounds of Survey,Respondents,Survey Methodology,Baseline Surveys,Design, Questionnaire,Designs, Questionnaire,Methods, Survey,Questionnaire Designs,Questionnaires and Surveys,Randomized Response Techniques,Response Technique, Randomized,Response Techniques, Randomized,Survey, Baseline,Survey, Community,Surveys, Baseline,Surveys, Community,Techniques, Randomized Response
D012042 Registries The systems and processes involved in the establishment, support, management, and operation of registers, e.g., disease registers. Parish Registers,Population Register,Parish Register,Population Registers,Register, Parish,Register, Population,Registers, Parish,Registers, Population,Registry
D003704 Dementia An acquired organic mental disorder with loss of intellectual abilities of sufficient severity to interfere with social or occupational functioning. The dysfunction is multifaceted and involves memory, behavior, personality, judgment, attention, spatial relations, language, abstract thought, and other executive functions. The intellectual decline is usually progressive, and initially spares the level of consciousness. Senile Paranoid Dementia,Amentia,Familial Dementia,Amentias,Dementia, Familial,Dementias,Dementias, Familial,Dementias, Senile Paranoid,Familial Dementias,Paranoid Dementia, Senile,Paranoid Dementias, Senile,Senile Paranoid Dementias
D005260 Female Females
D005387 Finland A country in northern Europe, bordering the Baltic Sea, Gulf of Bothnia, and Gulf of Finland, between Sweden and Russia. The capital is Helsinki. Aland Islands,Åland Islands
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

Paul Knekt, and Katri Sääksjärvi, and Ritva Järvinen, and Jukka Marniemi, and Satu Männistö, and Noora Kanerva, and Markku Heliövaara
September 2009, Journal of geriatric psychiatry and neurology,
Paul Knekt, and Katri Sääksjärvi, and Ritva Järvinen, and Jukka Marniemi, and Satu Männistö, and Noora Kanerva, and Markku Heliövaara
October 2007, Diabetes care,
Paul Knekt, and Katri Sääksjärvi, and Ritva Järvinen, and Jukka Marniemi, and Satu Männistö, and Noora Kanerva, and Markku Heliövaara
November 2020, Scientific reports,
Paul Knekt, and Katri Sääksjärvi, and Ritva Järvinen, and Jukka Marniemi, and Satu Männistö, and Noora Kanerva, and Markku Heliövaara
November 2013, Arteriosclerosis, thrombosis, and vascular biology,
Paul Knekt, and Katri Sääksjärvi, and Ritva Järvinen, and Jukka Marniemi, and Satu Männistö, and Noora Kanerva, and Markku Heliövaara
January 2015, Nutrition and cancer,
Paul Knekt, and Katri Sääksjärvi, and Ritva Järvinen, and Jukka Marniemi, and Satu Männistö, and Noora Kanerva, and Markku Heliövaara
January 2018, Diabetes,
Paul Knekt, and Katri Sääksjärvi, and Ritva Järvinen, and Jukka Marniemi, and Satu Männistö, and Noora Kanerva, and Markku Heliövaara
June 1983, Polski tygodnik lekarski (Warsaw, Poland : 1960),
Paul Knekt, and Katri Sääksjärvi, and Ritva Järvinen, and Jukka Marniemi, and Satu Männistö, and Noora Kanerva, and Markku Heliövaara
January 2014, Pediatrics,
Paul Knekt, and Katri Sääksjärvi, and Ritva Järvinen, and Jukka Marniemi, and Satu Männistö, and Noora Kanerva, and Markku Heliövaara
June 2013, Journal of the American Geriatrics Society,
Paul Knekt, and Katri Sääksjärvi, and Ritva Järvinen, and Jukka Marniemi, and Satu Männistö, and Noora Kanerva, and Markku Heliövaara
March 2011, Clinical endocrinology,
Copied contents to your clipboard!